dc.contributor.author | Erbas, B | |
dc.contributor.author | Uresin, Y | |
dc.contributor.author | Ozek, M | |
dc.date.accessioned | 2021-03-03T19:15:34Z | |
dc.date.available | 2021-03-03T19:15:34Z | |
dc.date.issued | 2004 | |
dc.identifier.citation | Uresin Y., Erbas B., Ozek M., "Losartan may prevent the elevation of plasma glucose levels induced by chronic stress", POLISH JOURNAL OF PHARMACOLOGY, cilt.56, sa.2, ss.271-273, 2004 | |
dc.identifier.issn | 1230-6002 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_538a7f51-8d86-4314-bdb3-99956a28d167 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/59229 | |
dc.identifier.uri | https://doi.org/10.3317/jraas.2004.017 | |
dc.description.abstract | The effect of angiotensin II antagonist, losartan, on chronic stress-induced elevation of blood glucose levels was investigated in rats. Chronic immobilization stress caused an increase in blood glucose levels in rats. Administration of losartan (3 mg/kg, po) before stress exposure significantly prevented this increment. We suggest that losartan showed this effect by decreasing the excessive sympathetic response to stress. In conclusion, there is a relationship between stress, sympathetic nervous system, and reninangiotensin system. | |
dc.language.iso | eng | |
dc.subject | Eczacılık | |
dc.subject | Temel Bilimler | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Yaşam Bilimleri | |
dc.title | Losartan may prevent the elevation of plasma glucose levels induced by chronic stress | |
dc.type | Makale | |
dc.relation.journal | POLISH JOURNAL OF PHARMACOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 56 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 271 | |
dc.identifier.endpage | 273 | |
dc.contributor.firstauthorID | 171010 | |